$373.85M
Revenue
$-79.66M
Net Income
59.58%
Gross Margin
-23.93%
Op. Margin
$86.13M
Free Cash Flow
| Breakdown | Q3 2026 (Oct 31, 2025) |
Q2 2026 (Jul 31, 2025) |
Q1 2025 (Apr 30, 2025) |
Q4 2025 (Jan 31, 2025) |
Q3 2025 (Oct 31, 2024) |
Q2 2025 (Jul 31, 2024) |
|---|---|---|---|---|---|---|
| Total Revenue | $108.45M | $95.51M | $85.87M | $84.02M | $82.65M | $63.72M |
| Revenue Growth % (YoY) | 31.2% | 49.9% | nan% | nan% | nan% | nan% |
| Cost of Revenue | $43.87M | $39.28M | $34.34M | $33.63M | $32.60M | $24.98M |
| Gross Profit | $64.59M | $56.23M | $51.54M | $50.38M | $50.05M | $38.74M |
| Gross Margin % | 59.6% | 58.9% | 60.0% | 60.0% | 60.6% | 60.8% |
| Operating Expenses | $80.83M | $78.22M | $77.39M | $75.73M | $75.56M | $75.03M |
| Research & Development | $61.45M | $59.73M | $58.82M | $56.82M | $58.39M | $56.76M |
| Selling General & Admin | $19.38M | $18.49M | $18.57M | $18.91M | $17.17M | $18.27M |
| Operating Income | $-16.25M | $-21.99M | $-25.86M | $-25.35M | $-25.51M | $-36.29M |
| Operating Margin % | -15.0% | -23.0% | -30.1% | -30.2% | -30.9% | -56.9% |
| Other Income/Expense | $2.07M | $2.25M | $2.17M | $2.36M | $2.09M | $2.15M |
| Income Before Tax | $-14.17M | $-19.74M | $-23.68M | $-22.99M | $-23.42M | $-34.14M |
| Income Tax Expense | $933.00K | $253.00K | $645.00K | $-2.76M | $652.00K | $747.00K |
| Net Income | $-15.11M | $-20.00M | $-24.33M | $-20.23M | $-24.07M | $-34.89M |
| Net Margin % | -13.9% | -20.9% | -28.3% | -24.1% | -29.1% | -54.8% |
| Basic EPS | -0.35 | -0.47 | -0.58 | -0.48 | -0.58 | -0.85 |
| Diluted EPS | -0.35 | -0.47 | -0.58 | -0.48 | -0.58 | -0.85 |
| Basic Shares Outstanding | 42.9M | 42.5M | 42.2M | 175K | 41.5M | 41.1M |
| Diluted Shares Outstanding | 42.9M | 42.5M | 42.2M | 175K | 41.5M | 41.1M |
| Breakdown | Q3 2026 (Oct 31, 2025) |
Q2 2026 (Jul 31, 2025) |
Q1 2025 (Apr 30, 2025) |
Q4 2025 (Jan 31, 2025) |
Q3 2025 (Oct 31, 2024) |
Q2 2025 (Jul 31, 2024) |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $174.06M | $142.74M | $141.28M | $144.62M | $127.12M | $153.93M |
| Accounts Receivable | $42.23M | $42.90M | $30.23M | $29.77M | $33.97M | $23.16M |
| Inventory | $39.16M | $33.81M | $39.29M | $34.43M | $36.59M | $30.66M |
| Other Current Assets | $6.54M | $5.54M | $6.20M | $6.08M | $6.52M | $6.05M |
| Total Current Assets | $383.67M | $343.87M | $335.55M | $320.55M | $303.61M | $279.68M |
| Property Plant & Equipment | $10.72M | $10.09M | $10.25M | $9.08M | $9.68M | $9.04M |
| Goodwill | $303.62M | $3.50M | $303.62M | $303.62M | $303.62M | $303.62M |
| Intangible Assets | $37.95M | $41.88M | $44.90M | $47.28M | $44.96M | $48.40M |
| Other Non-current Assets | $3.15M | $3.46M | $3.22M | $3.24M | $2.96M | $2.67M |
| Total Assets | $751.89M | $706.43M | $701.92M | $688.97M | $670.79M | $650.33M |
| Accounts Payable | $34.92M | $26.78M | $35.29M | $21.77M | $25.23M | $19.44M |
| Accrued Liabilities | $88.40M | $76.19M | $73.48M | $80.78M | $72.97M | $62.40M |
| Deferred Revenue | $17.51M | $19.48M | $12.11M | $14.23M | $4.58M | $5.15M |
| Total Current Liabilities | $144.45M | $125.94M | $124.85M | $120.99M | $106.87M | $91.46M |
| Other Non-current Liabilities | $5.41M | $2.30M | $2.29M | $4.13M | $6.91M | $8.23M |
| Total Liabilities | $161.78M | $129.91M | $129.20M | $127.56M | $116.49M | $102.78M |
| Common Stock | $19.00K | $19.00K | $19.00K | $19.00K | $19.00K | $19.00K |
| Retained Earnings | $-311.49M | $-296.38M | $-276.38M | $-252.06M | $-231.82M | $-207.75M |
| Total Stockholders Equity | $590.11M | $576.52M | $572.72M | $561.41M | $554.29M | $547.55M |
| Total Liabilities & Equity | $751.89M | $706.43M | $701.92M | $688.97M | $670.79M | $650.33M |
| Breakdown | Q3 2026 (Oct 31, 2025) |
Q2 2026 (Jul 31, 2025) |
Q1 2025 (Apr 30, 2025) |
Q4 2025 (Jan 31, 2025) |
Q3 2025 (Oct 31, 2024) |
Q2 2025 (Jul 31, 2024) |
|---|---|---|---|---|---|---|
| Net Income | $-15.11M | $-20.00M | $-24.33M | $-20.23M | $-96.89M | $-72.82M |
| Depreciation & Amortization | $19.90M | $13.38M | $6.75M | $6.83M | $19.23M | $12.76M |
| Stock-based Compensation | $77.06M | $51.32M | $26.13M | $27.31M | $80.50M | $53.65M |
| Change in Receivables | $12.46M | $13.13M | $468.00K | $-4.20M | $9.02M | $-1.79M |
| Change in Inventory | $4.78M | $-597.00K | $4.86M | $-2.16M | $7.37M | $1.42M |
| Change in Payables | $16.00M | $7.25M | $15.37M | $-6.30M | $-3.28M | $-9.06M |
| Operating Cash Flow | $54.62M | $20.31M | $14.80M | $25.43M | $8.41M | $1.79M |
| Capital Expenditure | $11.59M | $8.69M | $4.57M | $4.18M | $6.20M | $3.70M |
| Purchases of Investments | $53.16M | $34.57M | $21.05M | $13.33M | $57.34M | $8.26M |
| Sales of Investments | $23.57M | $17.51M | $8.03M | $3.52M | $15.61M | $8.47M |
| Investing Cash Flow | $-26.10M | $-21.10M | $-16.15M | $-10.47M | $-30.06M | $5.76M |
| Stock Repurchased | $1.00M | $1.00M | $1.00M | - | - | - |
| Financing Cash Flow | $1.35M | $-656.00K | $-1.55M | $2.54M | $3.86M | $1.47M |
| Net Change in Cash | $29.87M | $-1.45M | $-2.90M | $17.50M | $-17.79M | $9.01M |
SEC Filing Format - Data shown as it appears in the Q3 2026 (10-Q) filing
Period ended: Oct 31, 2025
Condensed Consolidated Statements of Operations
| Description | Oct 31, 2025 | Oct 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $108.45M | - | $289.83M | - |
| Cost of Revenue | $43.87M | - | $117.48M | - |
| Gross Profit | $64.59M | - | $172.35M | - |
| Operating Expenses | $80.83M | - | $236.45M | - |
| Research & Development | $61.45M | - | $180.00M | - |
| Selling General & Admin | $19.38M | - | $56.44M | - |
| Operating Income | $-16.25M | - | $-64.09M | - |
| Other Income/Expense | $2.07M | - | $6.50M | - |
| Income Before Tax | $-14.17M | - | $-57.60M | - |
| Income Tax Expense | $933.00K | - | $1.83M | - |
| Net Income | $-15.11M | $-34.89M | $-59.43M | - |
| Basic EPS | -0.35 | - | -1.40 | - |
| Diluted EPS | -0.35 | - | -1.40 | - |
| Basic Shares Outstanding | $42.87M | - | $42.54M | - |
| Diluted Shares Outstanding | $42.87M | - | $42.54M | - |
Condensed Consolidated Balance Sheets
| Description | Oct 31, 2025 | Jan 31, 2025 |
|---|---|---|
| Cash & Cash Equivalents | $174.06M | $144.62M |
| Accounts Receivable | $42.23M | $29.77M |
| Inventory | $39.16M | $34.43M |
| Other Current Assets | $6.54M | $6.08M |
| Total Current Assets | $383.67M | $320.55M |
| Property Plant & Equipment | $10.72M | $9.08M |
| Goodwill | $303.62M | $303.62M |
| Intangible Assets | $37.95M | $47.28M |
| Other Non-current Assets | $3.15M | $3.24M |
| Total Assets | $751.89M | $688.97M |
| Accounts Payable | $34.92M | $21.77M |
| Accrued Liabilities | $88.40M | $80.78M |
| Deferred Revenue | $17.51M | $14.23M |
| Total Current Liabilities | $144.45M | $120.99M |
| Other Non-current Liabilities | $5.41M | $4.13M |
| Total Liabilities | $161.78M | $127.56M |
| Common Stock | $19.00K | $19.00K |
| Retained Earnings | $-311.49M | $-252.06M |
| Total Stockholders Equity | $590.11M | $561.41M |
| Total Liabilities & Equity | $751.89M | $688.97M |
Condensed Consolidated Statements of Cash Flows
| Description | Oct 31, 2025 | Oct 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-15.11M | $-34.89M | $-59.43M | - |
| Depreciation & Amortization | - | - | $19.90M | - |
| Stock-based Compensation | - | - | $77.06M | - |
| Change in Receivables | - | - | $12.46M | - |
| Change in Inventory | - | - | $4.78M | - |
| Change in Payables | - | - | $16.00M | - |
| Operating Cash Flow | - | - | $54.62M | - |
| Capital Expenditure | - | - | $11.59M | - |
| Purchases of Investments | - | - | $53.16M | - |
| Sales of Investments | - | - | $23.57M | - |
| Investing Cash Flow | - | - | $-26.10M | - |
| Stock Repurchased | - | - | $1.00M | - |
| Financing Cash Flow | - | - | $1.35M | - |
| Net Change in Cash | - | - | $29.87M | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.